Intervention Review

Nicobrevin for smoking cessation

  1. Lindsay F Stead*,
  2. Tim Lancaster

Editorial Group: Cochrane Tobacco Addiction Group

Published Online: 15 APR 2009

Assessed as up-to-date: 7 JAN 2009

DOI: 10.1002/14651858.CD005990

Database Title

Additional Information

How to Cite

Stead LF, Lancaster T. Nicobrevin for smoking cessation. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD005990. DOI: 10.1002/14651858.CD005990.

Author Information

  1. University of Oxford, Department of Primary Health Care, Oxford, UK

*Lindsay F Stead, Department of Primary Health Care, University of Oxford, Rosemary Rue Building, Old Road Campus, Oxford, OX3 7LF, UK. lindsay.stead@dphpc.ox.ac.uk.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 15 APR 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (50K)Standard (94K)Full (94K)
 

Abstract

  1. Top of page
  2. Abstract
  3. Plain language summary
  4. 摘要

Background

Nicobrevin is a proprietary product marketed as an aid to smoking cessation. It contains quinine, menthyl valerate, camphor and eucalyptus oil.

Objectives

The objective of this review was to assess the effects of Nicobrevin on long term smoking cessation

Search methods

We searched the Cochrane Tobacco Addiction Group trials register. Most recent search was January 2009.

Selection criteria

Randomized trials comparing Nicobrevin to placebo or an alternative therapeutic control, which reported smoking cessation with at least six months follow up.

Data collection and analysis

Data were sought on the outcome, method of randomization, and completeness of follow up.

Main results

We identified no trials meeting the full inclusion criteria including long-term follow up.

Authors' conclusions

There is no evidence available from long-term trials that Nicobrevin can aid smoking cessation.

 

Plain language summary

  1. Top of page
  2. Abstract
  3. Plain language summary
  4. 摘要

Does nicobrevin help people to stop smoking

Nicobrevin is a proprietary product containing quinine, menthyl valerate, camphor and eucalyptus oil marketed as an aid to smoking cessation. No randomized trials with long term follow up of smoking status were identified, so there was no evidence to assess efficacy.

 

摘要

  1. Top of page
  2. Abstract
  3. Plain language summary
  4. 摘要

背景

使用Nicobrevin戒菸

Nicobrevin是一個有專利的產品,上市用來幫助戒菸。它包含奎寧，甲基戊酸，樟腦和桉樹油。

目標

這個回顧的目標為評估Nicobrevin在長期戒菸上的效果。

搜尋策略

我們搜尋了Cochrane Tobacco Addiction Group trials register的文獻。

選擇標準

比較Ｎicobrevin與安慰劑或另一種替代治療(控制組)對於戒煙的隨機對照試驗，同時至少要追蹤六個月以上

資料收集與分析

收集有關預後、隨機方法以及追蹤完成度的資料

主要結論

我們找不到任何符合納入條件的長期追蹤報告.

作者結論

沒有現有的長期的研究文獻來證明Nicobrevin可以協助戒菸。

翻譯人

本摘要由彰化基督教醫院李謙益翻譯。

此翻譯計畫由臺灣國家衛生研究院(National Health Research Institutes, Taiwan)統籌。

總結

沒有證據顯示Nicobrevin可以幫助長期戒菸. Nicobrevin是一個有專利的產品,它包含奎寧， 甲基戊酸，樟腦和桉樹油。它上市用來幫助戒菸。沒有發現長期追蹤的隨機分配試驗,所以沒有證據來評估其療效。

View Full Article (HTML) Summary (50K)Standard (94K)Full (94K)